Can long-term steroid use cause osteoporosis? 

Long-term use of oral corticosteroids (often called steroids or glucocorticoids) is a leading cause of secondary osteoporosis in the UK. While these medications are essential for treating various inflammatory and autoimmune conditions, they have a direct and significant impact on the strength of the skeleton. Unlike age-related bone loss, which happens slowly over decades, steroid-induced bone loss can occur very rapidly, with the most significant decline often seen within the first three to six months of starting treatment. Because of this high risk, UK healthcare guidelines mandate that anyone expected to be on steroids for more than three months should have their bone health formally assessed. 

What We’ll Discuss in This Article 

• The biological mechanism by which steroids weaken bone tissue 

• The definition of “long-term” use and “high-dose” risk 

• Why bone loss occurs so rapidly at the start of treatment 

• How steroids affect the body’s ability to use calcium and vitamin D 

• UK clinical protocols for protecting the bones of steroid users 

• Preventative measures to reduce the risk of steroid-induced fractures 

Steroids interfere with the body’s natural process of bone renewal. 

Bones are living tissues that are constantly being broken down and rebuilt in a balanced cycle. Steroids disrupt this delicate balance in two ways: they slow down the cells that build new bone (osteoblasts) and slightly increase the activity of the cells that break bone down (osteoclasts). This means that while the body continues to remove old bone, it is unable to replace it with enough fresh, strong tissue. 

Furthermore, steroids can cause the death of existing bone cells (osteocytes), which are responsible for maintaining the bone’s internal “scaffolding.” When these cells are lost, the architecture of the bone becomes thin and porous, significantly increasing the risk of a fracture. According to NHS guidance, oral steroid tablets (such as prednisolone) pose the highest risk because they are absorbed systemically throughout the entire body. 

Risk is determined by both the daily dosage and the duration of treatment. 

In the UK, “long-term” use is generally defined as taking oral steroid tablets for three months or more. However, research suggests that even low doses can impact bone density. A daily dose of as little as 2.5mg of prednisolone has been associated with an increased risk of fractures in some individuals. The higher the daily dose and the longer the treatment continues, the more significant the impact on the skeleton. 

It is important to note that the risk of fracture increases very quickly, often before a significant change can even be measured on a bone scan. For this reason, NICE guidelines recommend that bone-protective measures should be considered as soon as a patient starts a long-term course, rather than waiting for signs of weakness to appear. The risk is most pronounced in the spine and the hip, which are sites rich in “spongy” (trabecular) bone. 

Steroids affect how the body absorbs and manages essential bone minerals. 

Beyond their direct effect on bone cells, steroids interfere with the nutritional building blocks of the skeleton. They reduce the amount of calcium the body absorbs from food in the intestines and increase the amount of calcium excreted by the kidneys through urine. This “calcium drain” forces the body to pull calcium out of the bones to maintain steady levels in the blood, further weakening the skeletal structure. 

Steroids can also interfere with the activation of Vitamin D, which is necessary for calcium absorption. This is why UK healthcare providers almost always prescribe combined calcium and Vitamin D supplements to patients on long-term steroids. Ensuring these raw materials are available is a critical first step in mitigating the damaging effects of the medication on the bones. 

Proactive bone protection is a standard part of UK steroid therapy. 

If your doctor prescribes long-term steroids, they will typically follow a “bone-protection pathway.” For many patients, especially those over 65 or those who have previously broken a bone, this involves: 

• Risk Assessment: Using tools like FRAX to calculate the likelihood of a fracture. 

• DEXA Scan: A bone density scan to establish a baseline of your skeletal strength. 

• Prophylactic Medication: Prescribing bone-strengthening drugs, such as bisphosphonates, alongside the steroids to “lock” minerals into the bone and prevent thinning. 

• Lifestyle Advice: Encouraging weight-bearing exercise and smoking cessation, both of which are even more important when taking steroids. 

In some cases, if the steroid treatment is stopped, the risk of fracture can begin to decrease relatively quickly. However, the bone density lost during long-term use may not always fully return, making early prevention the most effective strategy. 

Other forms of steroids, such as inhalers or creams, have a lower risk. 

It is important to distinguish between different types of steroid treatments. While oral tablets carry the highest risk, other forms are generally considered much safer for the bones: 

• Inhaled Steroids: Used for asthma or COPD, these primarily stay in the lungs. While very high doses over many years might have a small effect, standard doses are unlikely to cause osteoporosis. 

• Steroid Creams: Used for skin conditions, these are absorbed in very small amounts and do not typically affect bone density. 

• Steroid Injections: Occasional injections into a joint (for arthritis) or a muscle are generally safe for the bones; however, frequent, repeated injections over a long period may require monitoring. 

Conclusion 

Long-term use of oral steroids is a well-recognised cause of osteoporosis due to their direct impact on bone-building cells and mineral absorption. Because bone loss can occur so rapidly at the start of therapy, proactive management, including risk assessments, nutritional support, and often bone-strengthening medication, is essential. By following UK clinical guidelines and maintaining a healthy lifestyle, the skeletal risks of steroid therapy can be significantly reduced. If you have been taking steroid tablets for more than three months, it is important to discuss a bone health review with your GP. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article examines the relationship between corticosteroid therapy and secondary osteoporosis. It has been written and reviewed by Dr. Stefan Petrov, a UK-trained physician, to ensure clinical accuracy and adherence to NHS standards. All information is strictly aligned with the latest clinical evidence and guidelines provided by the NHS and NICE regarding glucocorticoid-induced bone loss.